Clinical trial
Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating…
NCT00423930 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00423930 |
|---|---|
| Title | Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer |
| Official title | A Phase II Study of Radiotherapy (IMRT) + Cisplatin + Bevacizumab for Patients With Stage III/IV Head and Neck Cancers |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | bevacizumab, cisplatin, conventional surgery, intensity-modulated radiation therapy |
| Enrollment | 44 |
| Start date | Oct 1, 2006 |
| Primary completion | Jul 1, 2016 |
| Completion | Jul 1, 2016 |
| First posted | Jan 18, 2007 |
| Last update posted | Aug 18, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: